Case Study · Clin Pharm
Virtual Trial Population Simulations
Challenge
Traditional clinical trials, especially for pediatric populations, face challenges including recruitment difficulties, ethical concerns, and variability in pharmacokinetics. These obstacles often lead to larger sample sizes, higher costs, and longer trial durations.
Our Solution
We offer Virtual Trial Population Simulations, which leverage real-world data and advanced modeling to optimize trial designs. In a case study for Ceftazidime dosing in obese children and adolescents, our approach simulated various dosing regimens and determined the minimum sample size required to achieve reliable pharmacokinetic (PK) and efficacy outcomes.
Outcome
Our virtual trial demonstrated that only 60 patientsinstead of 100were needed to produce robust results, achieving a 31% reduction in cost and time. By providing accurate, ethical, and efficient trial simulations, we enable faster decision-making and streamlined drug development for complex populations.
Download our ceftzazidime case study by filling out the inquiry below!
Summary
- It was predicted that the generic drug (B) was bioequivalent to Tacrolimus based on both the Cmax and AUC criteria
| Traditional Approach | Virtual Trial Approach |
|---|---|
| 24-36 patients | 5-6 patients followed by simulation of 200 virtual patients |
| 6-12 months for recruitment, site management and data collection | Large savings in time - Trials completed in weeks, easy to implement complex protocols virtually |
| Multiple dosing periods, washouts, and extensive blood sampling | Big cost savings, up to 60-70% reduction |
Download case study
Get your questions answered by downloading the free pdf and learn more about our study!
Your information will be processed by Differentia to send you the content requested. For more information about our processing or to exercise your GDPR rights, see our Privacy Policy.